Pancreatic Cancer Research

ResearcherStanford MedicineActive in the last 2 years

Michael Thornton Longaker

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1430-8914; OpenAlex author ID A5005728573. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 3 papers · 2026: 2 papers

Papers 9

  1. NFAT mediates pro-tumorigenic inflammation in cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2025.116849↗
  2. Protocol for orthotopic implantation of a collagen hydrogel to model pancreatic ductal adenocarcinoma in mice. Co-author DOI 10.1016/j.xpro.2025.104337↗
  3. Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2025.116347↗
  4. Precision Medicine: IL-1RA and Pancreatic Cancer Organoids. Co-author DOI 10.3390/biology14060604↗
  5. Correction: Morgan et al. Precision Medicine: IL-1RA and Pancreatic Cancer Organoids. Biology 2025, 14, 604. Co-author DOI 10.3390/biology14091133↗
  6. Hematoxylin and Eosin Architecture Uncovers Clinically Divergent Niches in Pancreatic Cancer. Last author DOI 10.1089/ten.tea.2024.0039↗
  7. Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.xcrm.2023.101248↗
  8. Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer. Co-author DOI 10.3390/biology12081044↗
  9. Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment. Last author DOI 10.3390/cancers12051347↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jeffrey Allen Norton · 8 shared papers, 2020–2026 · strength 1.80
  2. Annah Grace Morgan · 4 shared papers, 2023–2026 · strength 1.17
  3. Deshka S. Foster · 6 shared papers, 2020–2026 · strength 1.12
  4. Daniel Delitto · 5 shared papers, 2023–2026 · strength 0.97
  5. Jason L. Guo · 4 shared papers, 2023–2026 · strength 0.70
  6. Maria Moozhiyil Korah · 3 shared papers, 2025–2026 · strength 0.66
  7. James Paul Agolia · 3 shared papers, 2025–2026 · strength 0.66
  8. Chuner Guo · 3 shared papers, 2025–2026 · strength 0.66
  9. George A. Poultsides · 2 shared papers, 2025–2026 · strength 0.39
  10. Brendan Christopher Visser · 2 shared papers, 2025–2026 · strength 0.39
  11. Shamik Mascharak · 2 shared papers, 2023–2024 · strength 0.31
  12. Teri A. Longacre · 2 shared papers, 2023–2024 · strength 0.31
  13. Byrne Lee · 1 shared paper, 2025 · strength 0.17
  14. Amanda Kirane · 1 shared paper, 2025 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.